All Stories

  1. Deciphering Roles of Placental Endoplasmic Reticulum Stress in Complicated Pregnancies and Beyond: The Power of Mouse Models
  2. The human placenta and its role in reproductive outcomes revisited
  3. Raised Leptin and Pappalysin2 cell-free RNAs are the hallmarks of pregnancies complicated by preeclampsia with fetal growth restriction
  4. Genetic Variants Associated With Preeclampsia and Maternal Serum sFLT1 Levels
  5. Single-cell RNA sequencing identifies CXADR as a fate determinant of the placental exchange surface
  6. GDF15 linked to maternal risk of nausea and vomiting during pregnancy
  7. Longitudinal profiling of the pregnancy plasma proteome through organic solvent precipitation and nano LC-MS/MS
  8. Placental Streptococcus agalactiae DNA is associated with neonatal unit admission and foetal pro-inflammatory cytokines in term infants
  9. Prediction of spontaneous preterm birth using supervised machine learning on metabolomic data: A case–cohort study
  10. Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study
  11. Objective measures of smoking and caffeine intake and the risk of adverse pregnancy outcomes
  12. Protocol for culturing the endocrine junctional zone of the mouse placenta in serum-free medium
  13. The human placenta exhibits a unique transcriptomic void
  14. Group B Streptococcus and the risk of perinatal morbidity and mortality following term labor
  15. Physiologically relevant culture medium Plasmax improves human placental trophoblast stem cell function
  16. Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction
  17. Perturbation of placental protein glycosylation by endoplasmic reticulum stress promotes maladaptation of maternal hepatic glucose metabolism
  18. The human placenta exhibits a unique transcriptomic void
  19. Impact of Metformin Treatment on Human Placental Energy Production and Oxidative Stress
  20. Placental sex-dependent spermine synthesis regulates trophoblast gene expression through acetyl-coA metabolism and histone acetylation
  21. Metabolomic Identification of a Novel, Externally Validated Predictive Test for Gestational Diabetes Mellitus
  22. Author Correction: Inherent mosaicism and extensive mutation of human placentas
  23. Erratum to: A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study
  24. Placental energy metabolism in health and disease—significance of development and implications for preeclampsia
  25. A Maternal Serum Metabolite Ratio Predicts Large for Gestational Age Infants at Term: A Prospective Cohort Study
  26. Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor
  27. Placental polyamines regulate acetyl-coA and histone acetylation in a sex-specific manner
  28. RNA-Seq reveals changes in human placental metabolism, transport and endocrinology across the first–second trimester transition
  29. The RNA landscape of the human placenta in health and disease
  30. Inherent mosaicism and extensive mutation of human placentas
  31. Batch effects account for the main findings of an in utero human intestinal bacterial colonization study
  32. Abnormal placental CD8 + T‐cell infiltration is a feature of fetal growth restriction and pre‐eclampsia
  33. Evolutionary History of Endogenous Human Herpesvirus 6 Reflects Human Migration out of Africa
  34. Fetal inheritance of chromosomally integrated human herpesvirus 6 predisposes the mother to pre-eclampsia
  35. A maternal serum metabolite ratio predicts fetal growth restriction at term
  36. P112 Activation of PIK3CA in a model of endometriosis may shed light on the pathogenesis of ovarian clear cell adenocarcinoma
  37. Author Correction: Human placenta has no microbiome but can contain potential pathogens
  38. IFPA meeting 2018 workshop report II: Abnormally invasive placenta; inflammation and infection; preeclampsia; gestational trophoblastic disease and drug delivery
  39. Role of soluble endoglin in BMP9 signaling
  40. Three-dimensional morphological analysis of placental terminal villi
  41. Human placenta has no microbiome but can contain potential pathogens
  42. The International Network for Evaluating Outcomes (iNeo) of neonates: evolution, progress and opportunities
  43. The association between first trimester AFP to PAPP-A ratio and placentally-related adverse pregnancy outcome
  44. 4-Hydroxyglutamate is a novel predictor of pre-eclampsia
  45. Human pregnancy zone protein stabilizes misfolded proteins including preeclampsia- and Alzheimer’s-associated amyloid beta peptide
  46. A lower maternal cortisol to cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia by many weeks
  47. 440: Low cortisol to cortisone ratio precedes pre-eclampsia (PE) and fetal growth restriction (FGR)
  48. Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice
  49. Correction to: Detecting eukaryotic microbiota with single-cell sensitivity in human tissue
  50. Detecting eukaryotic microbiota with single-cell sensitivity in human tissue
  51. Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study
  52. ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia
  53. Recognizing the reagent microbiome
  54. Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice
  55. Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia
  56. Estimating neonatal length of stay for babies born very preterm
  57. Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta
  58. Retosiban Prevents Stretch-Induced Human Myometrial Contractility and Delays Labor in Cynomolgus Monkeys
  59. Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers
  60. Birth weight to placenta weight ratio and its relationship to ultrasonic measurements, maternal and neonatal morbidity: A prospective cohort study of nulliparous women
  61. Age at menarche and the risk of operative delivery
  62. RNA-Seq reveals conservation of function among the yolk sacs of human, mouse and chicken
  63. RNA-seq reveals conservation of function among the yolk sacs of human, mouse, and chicken
  64. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor RatioNovelty and Significance
  65. 155: Screening for late fetal growth restriction using ultrasound and the sFlt-1:PlGF ratio
  66. Computational modeling of the structure-function relationship in human placental terminal villi
  67. Fetus-derived DLK1 is required for maternal metabolic adaptations to pregnancy and is associated with fetal growth restriction
  68. The pregnancy outcome prediction (POP) study: Investigating the relationship between serial prenatal ultrasonography, biomarkers, placental phenotype and adverse pregnancy outcomes
  69. Three-dimensional modeling of human placental terminal villi
  70. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia
  71. The relationship between human placental morphometry and ultrasonic measurements of utero-placental blood flow and fetal growth
  72. Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complications
  73. Leptin Matures Aspects of Lung Structure and Function in the Ovine Fetus
  74. Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma
  75. Age‐related changes in murine myometrial transcript profile are mediated by exposure to the female sex hormones
  76. The Effect of an Oxytocin Receptor Antagonist (Retosiban, GSK221149A) on the Response of Human Myometrial Explants to Prolonged Mechanical Stretch
  77. Morphological and molecular changes in the murine placenta exposed to normobaric hypoxia throughout pregnancy
  78. Developmental Expression and Glucocorticoid Control of the Leptin Receptor in Fetal Ovine Lung
  79. The acute-phase protein SAA3 is present in the preterm human colostrum and breast milk
  80. Energy status and HIF signalling in chorionic villi show no evidence of hypoxic stress during human early placental development
  81. Endoplasmic reticulum stress regulates placental growth factor expression in human choriocarcioma cells
  82. 3D surface reconstruction of human terminal villi and the fetal capillary bed
  83. Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early‐ and late‐onset pre‐eclampsia
  84. Influence of speed of sample processing on placental energetics and signalling pathways: Implications for tissue collection
  85. Phosphorylation changes in survival and stress-response signalling pathways in the human placenta as an artefact of delayed tissue collection
  86. Redefining Preeclampsia Using Placenta-Derived Biomarkers
  87. Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis
  88. Endoplasmic reticulum stress disrupts placental morphogenesis: implications for human intrauterine growth restriction
  89. Expression of gastrin‐releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility
  90. Proceedings of Research in Clinical Practice 2011
  91. A-Ring Dihalogenation Increases the Cellular Activity of Combretastatin-Templated Tetrazoles
  92. Increased endothelial cell selectivity of triazole-bridged dihalogenated A-ring analogues of combretastatin A–1
  93. Gene network inference and visualization tools for biologists: application to new human transcriptome datasets
  94. Disruption of paraoxonase 3 impairs proliferation and antioxidant defenses in human A549 cells and causes embryonic lethality in mice
  95. Ovarian clear cell carcinoma-bad endometriosis or bad endometrium?
  96. Functional analysis of the antioxidant paraoxonase-3 in lung epithelial cells by rna interference
  97. Dynamic expression and steroid regulation of sarg, a novel gene in the perinatal lung
  98. Estimating Genome-Wide Gene Networks Using Nonparametric Bayesian Network Models on Massively Parallel Computers
  99. Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis
  100. Regulation of AKT Phosphorylation at Ser473 and Thr308 by Endoplasmic Reticulum Stress Modulates Substrate Specificity in a Severity Dependent Manner
  101. The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo
  102. MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms
  103. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling
  104. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  105. VEGF-A loss in the haematopoietic and endothelial lineages exacerbates age-induced renal changes
  106. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine
  107. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  108. Effects of Medroxyprogesterone Acetate on Gene Expression in Myometrial Explants from Pregnant Women
  109. Paraoxonase-3, a Putative Circulating Antioxidant, Is Systemically Up-Regulated in Late Gestation in the Fetal Rat, Sheep, and Human
  110. VEGF-A and Serum Withdrawal Induced Changes in the Transcript Profile in Human Endometrial Endothelial Cells
  111. Antivascular and anticancer activity of dihalogenated A-ring analogues of combretastatin A-4
  112. The influence of the intrauterine environment on human placental development
  113. Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium
  114. Regulation of vascular growth and function in the human placenta
  115. Effect of low-dose mifepristone administration on day 2 after ovulation on transcript profiles in implantation-stage endometrium of rhesus monkeys
  116. Analysis of PPARα-dependent and PPARα-independent transcript regulation following fenofibrate treatment of human endothelial cells
  117. Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia
  118. Characterization of Serotonin Receptors in Pregnant Human Myometrium
  119. Study protocol. A prospective cohort study of unselected primiparous women: the pregnancy outcome prediction study
  120. UNRAVELING DYNAMIC ACTIVITIES OF AUTOCRINE PATHWAYS THAT CONTROL DRUG-RESPONSE TRANSCRIPTOME NETWORKS
  121. Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment
  122. Evidence of Placental Translation Inhibition and Endoplasmic Reticulum Stress in the Etiology of Human Intrauterine Growth Restriction
  123. Transcript profile and localization of Wnt signaling–related molecules in human endometrium
  124. The Effect of Delaying Childbirth on Primary Cesarean Section Rates
  125. Stimulation of Contractions in Human Myometrium by Serotonin is Unmasked by Smooth Muscle Relaxants
  126. Statistical inference of transcriptional module-based gene networks from time course gene expression profiles by using state space models
  127. Localization and Control of Expression of VEGF-A and the VEGFR-2 Receptor in Fetal Sheep Intestines
  128. Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration
  129. 325: Maternal age and uterine function: A biological basis for rising rates of cesarean delivery
  130. Oxidative Stress, Gene Expression, and Protein Changes Induced in the Human Placenta during Labor
  131. Understanding endothelial cell apoptosis: what can the transcriptome, glycome and proteome reveal?
  132. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium
  133. Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment
  134. Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta)
  135. Nuclear Factor-κB, p38, and Stress-Activated Protein Kinase Mitogen-Activated Protein Kinase Signaling Pathways Regulate Proinflammatory Cytokines and Apoptosis in Human Placental Explants in Response to Oxidative Stress
  136. Human Early Placental Development: Potential Roles of the Endometrial Glands
  137. Quantitative Cellular and Molecular Analysis of the Effect of Progesterone Withdrawal in a Murine Model of Decidualization
  138. Endoplasmic reticulum stress exacerbates ischemia‐reperfusion‐induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells
  139. Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2
  140. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia
  141. In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer
  142. Changes in Gene Expression during Wolffian Duct Development
  143. Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT
  144. COMPUTATIONAL STRATEGY FOR DISCOVERING DRUGGABLE GENE NETWORKS FROM GENOME-WIDE RNA EXPRESSION PROFILES
  145. Reply: Is the dose to inhibit the COX-2 enzyme in nude mice also adequate in human endometrial tissues?
  146. Inhibition of Stat3 activation in the endometrium prevents implantation: A nonsteroidal approach to contraception
  147. Vascular growth and modelling in the endometrium
  148. Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys
  149. Novel antiangiogenic agents for use in contraception
  150. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis
  151. 126. Progesterone regulates CXCL14 (macrophage inflammatory protein 2γ) mRNA in human endometrium
  152. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma
  153. Independent component analysis of microarray data in the study of endometrial cancer
  154. Secretion of Tumor Necrosis Factor-α from Human Placental Tissues Induced by Hypoxia-Reoxygenation Causes Endothelial Cell Activation in Vitro
  155. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. I. Molecular Regulation
  156. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. II. Changes During Normal Pregnancy
  157. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. III. Changes in Complicated Pregnancies
  158. Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF
  159. Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology
  160. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation
  161. Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology
  162. The effect of RU486 on the gene expression profile in an endometrial explant model
  163. Antiangiogenic Agents Are Effective Inhibitors of Endometriosis
  164. Intralobular Differences in Antioxidant Enzyme Expression and Activity Reflect the Pattern of Maternal Arterial Bloodflow Within the Human Placenta
  165. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor ☆☆This study was supported by grants from the Heart and Stroke Foundation of Ontario (T-3361) and the Canadian Institutes of Health Research (MT-1502...
  166. Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17β-Estradiol in the Mouse Uterus
  167. Identification of Genes with Differential Regulation in Primate Endometrium During the Proliferative and Secretory Phases of the Cycle
  168. Generation and use of a tailored gene array to investigate vascular biology
  169. Determination of the transcript profile of human endometrium
  170. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
  171. vavCre Transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineages
  172. Placental Vessel Adaptation During Gestation and to High Altitude: Changes in Diameter and Perivascular Cell Coverage
  173. Expression of CD105 (endoglin) in arteriolar endothelial cells of human endometrium throughout the menstrual cycle
  174. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function
  175. Is estradiol cardioprotection a nitric oxide-mediated effect?
  176. A longitudinal study of biochemical variables in women at risk of preeclampsia
  177. Hypoxia-Reoxygenation
  178. Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature*
  179. Soluble flt and the angiopoietins in the development and regulation of placental vasculature
  180. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window
  181. Large scale analysis of transcripts in human endometrium
  182. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs
  183. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs
  184. The Regulation and Localization of Angiopoietin-1, -2, and Their Receptor Tie2 in Normal and Pathologic Human Placentae
  185. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
  186. Angiogenesis and Blood Flow: Implications for Pathobiology—A Workshop Report
  187. Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells
  188. Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells1
  189. Placental Vascular Morphogenesis: Introduction and Overview
  190. Placental vascular morphogenesis
  191. Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey
  192. Changes in Tumorigenesis- and Angiogenesis-related Gene Transcript Abundance Profiles in Ovarian Cancer Detected by Tailored High Density cDNA Arrays
  193. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium
  194. Angiogenic growth factor expression in placenta
  195. Angiogenesis in reproduction
  196. Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia1
  197. Vascular Endothelial Growth Factor Expression in Human Endometrium Is Regulated by Hypoxia
  198. The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium
  199. Alternative Splicing of Vascular Endothelial Growth Factor (VEGF)-R1 (FLT-1) pre-mRNA Is Important for the Regulation of VEGF Activity
  200. Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy1
  201. A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1
  202. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
  203. Placental angiogenesis: the role of the VEGF family of proteins
  204. Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies
  205. Expression and Localization of the Th2-type Cytokine Interleukin-13 and Its Receptor in the Placenta During Human Pregnancy
  206. The role of leukaemia inhibitory factor and interleukin-6 in human reproduction
  207. Vascular endothelial growth factor and corpus luteum angiogenesis
  208. Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies
  209. VEGF mRNA Levels in Placentae From Pregnancies Complicated by Pre-Eclampsia
  210. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis
  211. Isolation of macrophages (Hofbauer cells) from human term placenta and their prostaglandin E2 and thromboxane production
  212. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium
  213. In-vivo gene transfer to the uterine endometrium
  214. Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis
  215. PGE2 and TXA2 Production by Isolated Macrophages from Human Placenta
  216. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia
  217. Hepatocyte growth factor/scatter factor and its receptor c-met: localisation and expression in the human placenta throughout pregnancy
  218. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia
  219. Messenger RNA encoding thiol protein disulphide isomerase in amnion, chorion and placenta in human term and preterm labour
  220. Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum
  221. Vascular Endothelial Growth Factor (VEGF) Concentrations Are Elevated in Peritoneal Fluid of Women With Endometriosis
  222. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.
  223. Expression of interleukin-13 by first trimester human villous trophoblast
  224. Hepatocyte growth factor and its receptor c-met: Localization and expression in the human placenta
  225. Localization of VEGF and expression of its receptors flit and KDR in human placenta throughout pregnancy
  226. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis
  227. Cloning, expression and genomic organization of human placental protein disulfide isomerase (previously identified as phospholipase C alpha)
  228. Expression of prostacyclin and thromboxane synthases in placenta and placental bed after pre-eclamptic pregnancies
  229. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry
  230. Stage-Specific Expression of Cytokine and Receptor Messenger Ribonucleic Acids in Human Preimplantation Embryos1
  231. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata.
  232. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata
  233. Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
  234. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
  235. Quantification of mRNA in Human Tissue Using Fluorescent Nested Reverse-Transcriptase Polymerase Chain Reaction
  236. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
  237. Extension of incomplete cDNAs (ESTs) by biotin/streptavidin-mediated walking using the polymerase chain reaction
  238. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction.
  239. Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction
  240. Capture PCR: An Efficient Method for Walking Along Chromosomal DNA and cDNA
  241. Expression of mRNA for vascular endothelial growth factor in human placenta
  242. Alternatively Spliced mRNAs for Human Endothelin-2 and Their Tissue Distribution
  243. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines
  244. Endothelin-2 mRNA Splice Variants Detected by RT-PCP in Cultured Human Vascular Smooth Muscle and Endothelial Cells
  245. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction
  246. [91] Fluorescent and radioactive solid-phase dideoxy sequencing of polymerase chain reaction products in microtiter plates
  247. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.
  248. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle
  249. Expression of messenger RNA for kit-ligand in human placenta: localization by in situ hybridization and identification of alternatively spliced variants
  250. Expression of messenger RNA for kit-ligand in human placenta: localization by in situ hybridization and identification of alternatively spliced variants.
  251. New protocols for DNA sequencing with dye terminators
  252. Evidence against a role for blastocyst-secreted oxytocin in early pregnancy maintenance in sheep
  253. Identification of mRNA for epidermal growth factor and transforming growth factor-α present in low copy number in human endometrium and decidua using reverse transcriptase-polymerase chain reaction
  254. Cloning and characterization of a gene encoding pig epidermal growth factor
  255. Fluorescent and radioactive solid phase dideoxy sequencing of per products in microtitre plates
  256. PCR walking from microdissection clone M54 identifies three exons from the human gene for the neural cell adhesion molecule L1 (CAM-L1)
  257. Luteal oxytocin: characteristics and control of synchronous episodes of oxytocin and PGF2α secretion at luteolysis in ruminants
  258. Genomic walking and sequencing by oligo-cassette mediated polymerase chain reaction
  259. A rapid semi-automated microtiter plate method for analysis and sequencing by PCR from bacterial stocks
  260. Nucleotide sequence of a full length cDNA clone encoding the oxytocin-neurophysin I precursor isolated from the ovine corpus luteum
  261. Concentrations of oxytocin-neurophysin prohormone mRNA in corpora lutea of sheep during the oestrous cycle and in early pregnancy
  262. The contribution of recombinant DNA techniques to reproductive biology
  263. Does the human corpus luteum synthesize neurohypophysial hormones?
  264. Linear Amplification Sequencing with Dye Terminators
  265. Working with Oxygen and Oxidative Stress In Vitro
  266. Angiogenesis and Vascular Endothelial Growth Factor (VEGF) in Reproduction